Speaking about the decision not to make a qualifying offer to free agent Torii Hunter on Friday, Angels GM Jerry Dipoto said he intends to go young and cheap in the outfield next season.
That means it’ll likely be Mike Trout in left, Peter Bourjos in center and Mark Trumbo in right on Opening Day.
“It wasn’t that we couldn’t fit Torii’s salary in” Dipoto said. “We made the decision to allow Trout, Trumbo and Bourjos to play on an every-day basis.”
That’s quite a change from last season, when Bourjos turned into nothing more than a defensive replacement after losing his job to Trout. He started just two games during the final two months, one of those coming in the final series after the Angels were eliminated. He had a total of two plate appearances in a seven-week span between Aug. 10 and Sept. 30.
Bourjos, though, is perhaps the game’s best defensive center fielder and one of the few people on the planet who could push Trout into a corner. Many believed Trout should have won a Gold Glove for his play in center last season.
Trumbo, a natural first baseman, got a brief look at third to begin last season, but that didn’t go to well. He went on to hit his way into the outfield picture and make 97 starts between left and right. However, his offense performance cratered after he made his first All-Star team in July; he hit just .227/.271/.359 with 10 homers and an 88/14 K/BB ratio in 256 at-bats after the break.
Besides leaving no room for Hunter, Dipoto’s decision also means Vernon Wells will be a $21 million fourth outfielder unless the Angels can trade him. He’s set to make about 10 times as much as the three starters ahead of him combined.
In a recent interview with Jon Greenberg of The Athletic, White Sox third baseman Todd Frazier took a swipe at the Reds’ front office. The rebuilding Reds traded Frazier to the White Sox as part of a three-team deal this past December.
After the season, Frazier will enter his third and final year of arbitration eligibility. Frazier told Greenberg he’d like to stay with the White Sox. He praised the club’s ownership and then, unprompted, he decided to castigate the Reds’ front office.
I would love to stay here. It’s a great club, great ownership. It was very different in Cincinnati, it wasn’t good. The bottom line here is these guys know what they’re doing. I see the guys [Hahn] gets, he’s not afraid to pull the trigger. You’ve got to have a guy like that. Whether it turns out to be for the best or not, you take a chance sometimes, and I think he’s done that a lot. It’s up to Jerry [Reinsdorf, owner] and Rick [Hahn, VP/GM] and their team to figure out what they want to do and it’s up to them.
It’s not clear if there are specific incidences to which Frazier could be alluding, but it’s a very obvious piece of criticism.
Frazier, 30, has regressed a bit offensively compared to the previous two seasons, batting .213/.295/.448 with 32 home runs and 81 RBI in 532 plate appearances. The White Sox could pursue trading him during the offseason.
Update (7:20 PM EDT): John Hickey of the Bay Area News Group reports that Crisp has indeed been traded, but there won’t be an official announcement until Wednesday. Crisp has already left the Athletics’ clubhouse.
Steve Adams of MLB Trade Rumors is reporting that the Athletics and Indians are making progress on a trade that would send outfielder Coco Crisp to Cleveland. Jon Morosi of FOX Sports confirms Adams’ report. Crisp, who has 10-and-5 rights, has waived them in order to facilitate a deal.
Crisp, 36, is owed the remainder of his $11 million salary for the 2016 season and has a $13 million option for the 2017 season that vests if he reaches 550 plate appearances or plays in 130 games this season. He has already played in 102 games and logged 434 PA, batting .234/.299/.399 with 11 home runs and 47 RBI.
The Indians are still looking to bolster the outfield. Michael Brantley is expected to miss the rest of the season, Bradley Zimmer may not yet be ready for the majors, and Abraham Almonte is not eligible to play in the postseason after testing positive for boldenone in February.